266 related articles for article (PubMed ID: 34112234)
1. Characterization of substantia nigra neurogenesis in homeostasis and dopaminergic degeneration: beneficial effects of the microneurotrophin BNN-20.
Mourtzi T; Dimitrakopoulos D; Kakogiannis D; Salodimitris C; Botsakis K; Meri DK; Anesti M; Dimopoulou A; Charalampopoulos I; Gravanis A; Matsokis N; Angelatou F; Kazanis I
Stem Cell Res Ther; 2021 Jun; 12(1):335. PubMed ID: 34112234
[TBL] [Abstract][Full Text] [Related]
2. Evidence for neurogenesis in the adult mammalian substantia nigra.
Zhao M; Momma S; Delfani K; Carlen M; Cassidy RM; Johansson CB; Brismar H; Shupliakov O; Frisen J; Janson AM
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7925-30. PubMed ID: 12792021
[TBL] [Abstract][Full Text] [Related]
3. Unravelling cell type-specific responses to Parkinson's Disease at single cell resolution.
Martirosyan A; Ansari R; Pestana F; Hebestreit K; Gasparyan H; Aleksanyan R; Hnatova S; Poovathingal S; Marneffe C; Thal DR; Kottick A; Hanson-Smith VJ; Guelfi S; Plumbly W; Belgard TG; Metzakopian E; Holt MG
Mol Neurodegener; 2024 Jan; 19(1):7. PubMed ID: 38245794
[TBL] [Abstract][Full Text] [Related]
4. Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.
Currim F; Tanwar R; Brown-Leung JM; Paranjape N; Liu J; Sanders LH; Doorn JA; Cannon JR
Neurotoxicology; 2024 Jul; ():. PubMed ID: 38964509
[TBL] [Abstract][Full Text] [Related]
5.
Qiao CM; Huang WY; Zhou Y; Quan W; Niu GY; Li T; Zhang MX; Wu J; Zhao LP; Zhao WJ; Cui C; Shen YQ
Brain Sci; 2024 Feb; 14(3):. PubMed ID: 38539626
[TBL] [Abstract][Full Text] [Related]
6. The raphe nuclei are the early lesion site of gastric
Zhang C; Bo R; Zhou T; Chen N; Yuan Y
Acta Pharm Sin B; 2024 May; 14(5):2057-2076. PubMed ID: 38799632
[TBL] [Abstract][Full Text] [Related]
7. Emerging regenerative medicine and tissue engineering strategies for Parkinson's disease.
Harris JP; Burrell JC; Struzyna LA; Chen HI; Serruya MD; Wolf JA; Duda JE; Cullen DK
NPJ Parkinsons Dis; 2020; 6():4. PubMed ID: 31934611
[TBL] [Abstract][Full Text] [Related]
8. Chronic consumption of cassava juice induces cellular stress in rat substantia nigra.
Rosas-Jarquín CJ; Rivadeneyra-Domínguez E; León-Chávez BA; Nadella R; Sánchez-García ADC; Rembao-Bojórquez D; Rodríguez-Landa JF; Hernandez-Baltazar D
Iran J Basic Med Sci; 2020 Jan; 23(1):93-101. PubMed ID: 32405352
[TBL] [Abstract][Full Text] [Related]
9. Umbilical cord: an unlimited source of cells differentiable towards dopaminergic neurons.
Boroujeni ME; Gardaneh M
Neural Regen Res; 2017 Jul; 12(7):1186-1192. PubMed ID: 28852404
[TBL] [Abstract][Full Text] [Related]
10. Iron toxicity, ferroptosis and microbiota in Parkinson's disease: Implications for novel targets.
Carvalho FV; Landis HE; Getachew B; Silva VDA; Ribeiro PR; Aschner M; Tizabi Y
Adv Neurotoxicol; 2024; 11():105-132. PubMed ID: 38770370
[TBL] [Abstract][Full Text] [Related]
11. Genes for endosomal pH regulators NHE6 and NHE9 are dysregulated in the substantia nigra in parkinson's disease.
Prasad H
Gene; 2024 Jun; ():148737. PubMed ID: 38945311
[TBL] [Abstract][Full Text] [Related]
12. An implantable piezoelectric ultrasound stimulator (ImPULS) for deep brain activation.
Hou JF; Nayeem MOG; Caplan KA; Ruesch EA; Caban-Murillo A; Criado-Hidalgo E; Ornellas SB; Williams B; Pearce AA; Dagdeviren HE; Surets M; White JA; Shapiro MG; Wang F; Ramirez S; Dagdeviren C
Nat Commun; 2024 Jun; 15(1):4601. PubMed ID: 38834558
[TBL] [Abstract][Full Text] [Related]
13. RNA-sequencing suggests extracellular matrix and vasculature dysregulation could impair neurogenesis in schizophrenia cases with elevated inflammation.
North HF; Weissleder C; Bitar M; Barry G; Fullerton JM; Webster MJ; Weickert CS
Schizophrenia (Heidelb); 2024 May; 10(1):50. PubMed ID: 38704390
[TBL] [Abstract][Full Text] [Related]
14. Correction: Embryonic and postnatal neurogenesis produce functionally distinct subclasses of dopaminergic neuron.
Galliano E; Franzoni E; Breton M; Chand AN; Byrne DJ; Murthy VN; Grubb MS
Elife; 2024 May; 13():. PubMed ID: 38728073
[No Abstract] [Full Text] [Related]
15. Tracing single-cell histories.
Lee JH
Science; 2018 Feb; 359(6375):521-522. PubMed ID: 29420280
[No Abstract] [Full Text] [Related]
16. Phenotypic manifestation of α-synuclein strains derived from Parkinson's disease and multiple system atrophy in human dopaminergic neurons.
Tanudjojo B; Shaikh SS; Fenyi A; Bousset L; Agarwal D; Marsh J; Zois C; Heman-Ackah S; Fischer R; Sims D; Melki R; Tofaris GK
Nat Commun; 2021 Jun; 12(1):3817. PubMed ID: 34155194
[TBL] [Abstract][Full Text] [Related]
17. Progress towards therapies for disease modification in Parkinson's disease.
Vijiaratnam N; Simuni T; Bandmann O; Morris HR; Foltynie T
Lancet Neurol; 2021 Jul; 20(7):559-572. PubMed ID: 34146514
[TBL] [Abstract][Full Text] [Related]
18. NPT520-34 improves neuropathology and motor deficits in a transgenic mouse model of Parkinson's disease.
Khan A; Johnson R; Wittmer C; Maile M; Tatsukawa K; Wong JL; Gill MB; Stocking EM; Natala SR; Paulino AD; Bowden-Verhoek JK; Wrasidlo W; Masliah E; Bonhaus DW; Price DL
Brain; 2021 Dec; 144(12):3692-3709. PubMed ID: 34117864
[TBL] [Abstract][Full Text] [Related]
19. Isolation of neural stem and oligodendrocyte progenitor cells from the brain of live rats.
McClenahan F; Dimitriou C; Koutsakis C; Dimitrakopoulos D; Arampatzis A; Kakouri P; Kourla M; Oikonomou S; Andreopoulou E; Patsonis M; Meri DK; Rasool RT; Franklin RJ; Kazanis I
Stem Cell Reports; 2021 Oct; 16(10):2534-2547. PubMed ID: 34560001
[TBL] [Abstract][Full Text] [Related]
20. α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity.
Santos J; Gracia P; Navarro S; Peña-Díaz S; Pujols J; Cremades N; Pallarès I; Ventura S
Nat Commun; 2021 Jun; 12(1):3752. PubMed ID: 34145261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
